These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 18096871)

  • 21. Moraxella catarrhalis: from interactions with the host immune system to vaccine development.
    Su YC; Singh B; Riesbeck K
    Future Microbiol; 2012 Sep; 7(9):1073-100. PubMed ID: 22953708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular aspects of Moraxella catarrhalis pathogenesis.
    de Vries SP; Bootsma HJ; Hays JP; Hermans PW
    Microbiol Mol Biol Rev; 2009 Sep; 73(3):389-406, Table of Contents. PubMed ID: 19721084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The adhesion mechanism of lactic acid bacteria bound to intestine through sugar chain].
    Yamamoto K; Wada J
    Seikagaku; 2001 May; 73(5):382-5. PubMed ID: 11452447
    [No Abstract]   [Full Text] [Related]  

  • 24. The biology and biochemistry of antichymotrypsin and its potential role as a therapeutic agent.
    Rubin H
    Biol Chem Hoppe Seyler; 1992 Jul; 373(7):497-502. PubMed ID: 1515081
    [No Abstract]   [Full Text] [Related]  

  • 25. [Is Moraxella pathogenic? The problem and its possible solutions].
    Kalina GP; Trukhina GM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jan; (1):80-8. PubMed ID: 2896415
    [No Abstract]   [Full Text] [Related]  

  • 26. Moraxella-dependent alpha 1-antichymotrypsin neutralization: a unique virulence mechanism.
    Manolov T; Tan TT; Forsgren A; Riesbeck K
    Am J Respir Cell Mol Biol; 2008 May; 38(5):609-17. PubMed ID: 18096871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MID and UspA1/A2 of the human respiratory pathogen Moraxella catarrhalis, and interactions with the human host as basis for vaccine development.
    Riesbeck K; Tan TT; Forsgren A
    Acta Biochim Pol; 2006; 53(3):445-56. PubMed ID: 16964325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virulence mechanisms of Moraxella in the pathogenesis of infection.
    Perez Vidakovics ML; Riesbeck K
    Curr Opin Infect Dis; 2009 Jun; 22(3):279-85. PubMed ID: 19405217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current progress of adhesins as vaccine candidates for Moraxella catarrhalis.
    Tan TT; Riesbeck K
    Expert Rev Vaccines; 2007 Dec; 6(6):949-56. PubMed ID: 18377357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of Haemophilus spp. and Branhamella catarrhalis in upper respiratory tract infections.
    Russo G; Stefani S; Oliveri S
    J Chemother; 1991 Jan; 3 Suppl 1():15-8. PubMed ID: 12041752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of oral beta-lactam antimicrobial agents versus respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the era of antibiotic resistance.
    Doern GV
    Otolaryngol Head Neck Surg; 2002 Dec; 127(6 Suppl):S17-23. PubMed ID: 12511856
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.